Tscan Therapeutics Inc (TCRX) earnings · rev $10.3M
These earnings events as JSON? API free 100/dayTscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
This TCRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TCRX revenue for 2025-12-31 was $10.3M. Net income was -$129.8M. Revenue was up 266.7% from 2024-12-31 to 2025-12-31. TCRX currently screens at market cap $62.1M.
When the next TCRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 266.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TCRX research stays on the stock page; the tape stays on the quote page.
TCRX earnings FAQ
What are TCRX's latest revenue and net income?
Latest cached Tscan Therapeutics Inc (TCRX) revenue for Dec 31, 2025 was $10.3M. Net income was -$129.8M. Statements: https://lician.com/financials/tcrx
What is TCRX's latest diluted EPS?
Latest cached Tscan Therapeutics Inc (TCRX) diluted EPS for Dec 31, 2025 was -$1.00.
What period does the latest TCRX earnings print cover?
The latest cached Tscan Therapeutics Inc (TCRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TCRX revenue change from the prior cached period?
Cached Tscan Therapeutics Inc (TCRX) revenue was up 266.7% from $2.8M (Dec 31, 2024) to $10.3M (Dec 31, 2025). Statements: https://lician.com/financials/tcrx
Where are TCRX earnings listed?
Cached earnings facts for Tscan Therapeutics Inc (TCRX) are listed at https://lician.com/earnings/tcrx. Statements: https://lician.com/financials/tcrx
Not investment advice.